Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,043.00
-23.00 (-2.16%)
Aug 19, 2026, 5:24 PM IDT
TLV:REKA Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.7 | 4.34 | 7.03 | 19.31 | 20.21 | 18.6 |
Trading Asset Securities | - | 0.04 | 0.04 | 0.04 | 0.08 | 0.04 |
Cash & Short-Term Investments | 6.74 | 4.38 | 7.07 | 19.35 | 20.29 | 18.64 |
Cash Growth | -13.55% | -38.09% | -63.48% | -4.63% | 8.83% | -49.53% |
Accounts Receivable | 130.6 | 126.35 | 127.11 | 117.68 | 120.71 | 107.37 |
Other Receivables | 9.62 | 9.05 | 8.55 | 8.67 | 6.83 | 2.25 |
Receivables | 140.22 | 135.4 | 135.66 | 126.35 | 127.54 | 109.62 |
Inventory | 92.97 | 91.01 | 82.48 | 96.6 | 92.2 | 89.61 |
Prepaid Expenses | - | 1.7 | 2.63 | 1.94 | 1.83 | 1.42 |
Other Current Assets | - | 0.21 | 1.22 | 7.09 | 1.28 | 2.37 |
Total Current Assets | 239.94 | 232.68 | 229.05 | 251.33 | 243.14 | 221.66 |
Property, Plant & Equipment | 121.82 | 126.46 | 140.07 | 154.62 | 163.21 | 177 |
Long-Term Investments | 1.32 | 1.17 | 1.18 | 1.17 | - | - |
Goodwill | 35.14 | 35.14 | 35.14 | 35.14 | 15.18 | - |
Other Intangible Assets | 20.13 | 21.12 | 25.7 | 31.66 | 20.67 | 32.97 |
Long-Term Deferred Tax Assets | 3.66 | 7.1 | 16.07 | 10.79 | 6.22 | 5.46 |
Other Long-Term Assets | - | - | - | 0.01 | 0.01 | 0.01 |
Total Assets | 421.99 | 423.68 | 447.22 | 484.72 | 448.42 | 437.09 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 101.12 | 86.37 | 87.29 | 78.89 | 81.21 | 57.44 |
Accrued Expenses | - | 22.3 | 20.98 | 23.95 | 17.05 | 13.61 |
Short-Term Debt | 31.64 | 9.39 | 14.35 | 3.12 | - | 0.01 |
Current Portion of Long-Term Debt | - | 15.88 | 15.2 | 24.8 | 30.9 | 18.96 |
Current Portion of Leases | 7.98 | 7.59 | 7.29 | 6.9 | 5.59 | 5.03 |
Current Income Taxes Payable | - | - | 0.35 | 1.56 | 0.76 | 0.26 |
Current Unearned Revenue | - | 0.23 | 0.24 | 0.13 | 0.1 | 0.25 |
Other Current Liabilities | 22.88 | 10.1 | 12.36 | 4.45 | 3.44 | 3.04 |
Total Current Liabilities | 163.61 | 151.87 | 158.04 | 143.79 | 139.03 | 98.61 |
Long-Term Debt | 62.71 | 68.5 | 63.62 | 110.09 | 91.66 | 101.23 |
Long-Term Leases | 29.41 | 31.03 | 33.7 | 38.76 | 37.55 | 40.6 |
Pension & Post-Retirement Benefits | 11.25 | 11.26 | 10.58 | 9.74 | 8.86 | 9.22 |
Long-Term Deferred Tax Liabilities | 1.47 | 4.94 | 5.27 | 6.03 | 2.75 | 3.16 |
Other Long-Term Liabilities | 12 | 11.88 | 14.02 | 20.74 | 6.49 | 11.21 |
Total Liabilities | 280.45 | 279.47 | 285.24 | 329.14 | 286.34 | 264.03 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 |
Additional Paid-In Capital | 126.61 | 126.61 | 126.61 | 126.61 | 126.61 | 126.61 |
Retained Earnings | 0.72 | 3.39 | 21.19 | 14.67 | 21.35 | 32.73 |
Treasury Stock | -0.51 | -0.51 | -0.51 | -0.51 | -0.51 | -0.51 |
Comprehensive Income & Other | 1.03 | 1.03 | 0.99 | 1.12 | 0.93 | 0.54 |
Total Common Equity | 141.5 | 144.16 | 161.93 | 155.54 | 162.03 | 173.01 |
Minority Interest | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Shareholders' Equity | 141.54 | 144.21 | 161.98 | 155.59 | 162.08 | 173.07 |
Total Liabilities & Equity | 421.99 | 423.68 | 447.22 | 484.72 | 448.42 | 437.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 131.73 | 132.39 | 134.16 | 183.66 | 165.7 | 165.82 |
Net Cash (Debt) | -124.99 | -128.01 | -127.09 | -164.31 | -145.41 | -147.18 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -10.94 | -11.21 | -11.13 | -14.39 | -12.74 | -12.89 |
Filing Date Shares Outstanding | 11.5 | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 |
Total Common Shares Outstanding | 11.5 | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 |
Working Capital | 76.33 | 80.82 | 71.01 | 107.54 | 104.11 | 123.05 |
Book Value Per Share | 12.30 | 12.63 | 14.19 | 13.63 | 14.19 | 15.16 |
Tangible Book Value | 86.23 | 87.89 | 101.09 | 88.73 | 126.18 | 140.05 |
Tangible Book Value Per Share | 7.50 | 7.70 | 8.86 | 7.77 | 11.05 | 12.27 |
Land | - | 1.89 | 1.89 | 1.89 | 2.07 | 2.07 |
Buildings | - | 120.11 | 119.29 | 117.94 | 124.71 | 122.66 |
Machinery | - | 130.24 | 125.12 | 121.03 | 112.99 | 109.84 |
Leasehold Improvements | - | 63.34 | 63.16 | 61.15 | 58.28 | 57.23 |